Company / Interest Expense per Share
IRONWOOD PHARMACEUTICALS INC Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.14
FY2023
5-year range
$0.14 / $0.19
FY2019-FY2023
Trend
-22.8%
vs FY2022
Sector context
#22 of 43
Health Care
What the data says
At $0.14, IRONWOOD PHARMACEUTICALS INC's interest expense per share ranks #22 of 43 in the Health Care sector. Interest Expense per Share has declined for 3 consecutive years, from $0.24 in FY2020 to $0.14 in FY2023.
Based on SEC 10-K filings.
0.14 in FY2023 with a 5-year CAGR of -12.3%.
Improved from $0.19 to $0.14 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -16.3%
- 5-Year CAGR
- -12.3%
- 10-Year CAGR
- -
Sector benchmark
#22 of 43 in Health CareTop 49% of 43This company $0.14 Sector average $9.80
▼
-98.6% below sector average
Key checks
Key Insights
- IRONWOOD PHARMACEUTICALS INC's interest expense per share has declined for 3 consecutive years.
- In FY2023, interest expense per share decreased 22.8% year-over-year.
- Ranks #22 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.14 | -22.8% |
| FY2022 | $0.18 | -6.2% |
| FY2021 | $0.19 | -19.0% |
| FY2020 | $0.24 | +1.0% |
| FY2019 | $0.24 | -12.3% |
| FY2018 | $0.27 | +5.6% |
| FY2017 | $0.26 | -10.6% |
| FY2016 | $0.29 | +6.6% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026